Previously doing business as Microbion Corporation in Alaska, the firm relocated to Montana, in 2005 Microbion BioSciences Corporation, a pharmaceutical company, develops bismuth-thiols based pharmaceuticals. Its bismuth-thiols are a class of compounds against antibiotic-resistant bacteria with anti-infective/anti-biofilm properties for drug, medical device, and industrial applications. With facailites also in Vanouver BC, Canada, Microbion focuses on the development of bismuth-thiols to prevent microbial biofilms from forming on medical devices implanted in the body; and to prevent microbial biofilms in agricultural crops and industrial surfaces, including shipsâ hulls, pulp and paper, and oil industries. These bismuth-thiol compounds to prevent microbial biofilms from contaminating water and water filtration units that affect drinking water, wastewater, desalinization, and industrial cooling water, as well as industrial surfaces
